nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP3A4—breast cancer	0.2	1	CbGaD
Imiquimod—CYP1A2—Anastrozole—breast cancer	0.0544	0.13	CbGbCtD
Imiquimod—CYP1A2—Toremifene—breast cancer	0.0498	0.119	CbGbCtD
Imiquimod—CYP3A4—Exemestane—breast cancer	0.0376	0.0898	CbGbCtD
Imiquimod—CYP3A4—Letrozole—breast cancer	0.032	0.0763	CbGbCtD
Imiquimod—CYP3A4—Anastrozole—breast cancer	0.0285	0.0681	CbGbCtD
Imiquimod—CYP3A4—Toremifene—breast cancer	0.0261	0.0622	CbGbCtD
Imiquimod—CYP3A4—Fulvestrant—breast cancer	0.0242	0.0579	CbGbCtD
Imiquimod—CYP3A4—Thiotepa—breast cancer	0.0216	0.0516	CbGbCtD
Imiquimod—CYP3A4—Ixabepilone—breast cancer	0.0198	0.0472	CbGbCtD
Imiquimod—CYP3A4—Lapatinib—breast cancer	0.019	0.0454	CbGbCtD
Imiquimod—CYP1A2—Tamoxifen—breast cancer	0.0182	0.0434	CbGbCtD
Imiquimod—CYP3A4—Raloxifene—breast cancer	0.0144	0.0344	CbGbCtD
Imiquimod—CYP1A2—Fluorouracil—breast cancer	0.0134	0.032	CbGbCtD
Imiquimod—CYP3A4—Vinorelbine—breast cancer	0.0105	0.0252	CbGbCtD
Imiquimod—CYP3A4—Tamoxifen—breast cancer	0.00952	0.0227	CbGbCtD
Imiquimod—CYP3A4—Mitoxantrone—breast cancer	0.00929	0.0222	CbGbCtD
Imiquimod—CYP3A4—Paclitaxel—breast cancer	0.00741	0.0177	CbGbCtD
Imiquimod—CYP3A4—Irinotecan—breast cancer	0.00731	0.0175	CbGbCtD
Imiquimod—CYP3A4—Vinblastine—breast cancer	0.0065	0.0155	CbGbCtD
Imiquimod—CYP3A4—Docetaxel—breast cancer	0.00536	0.0128	CbGbCtD
Imiquimod—TLR8—adipose tissue—breast cancer	0.00525	0.14	CbGeAlD
Imiquimod—TLR8—female reproductive system—breast cancer	0.00482	0.128	CbGeAlD
Imiquimod—TLR8—bone marrow—breast cancer	0.00455	0.121	CbGeAlD
Imiquimod—TLR8—endocrine gland—breast cancer	0.00408	0.109	CbGeAlD
Imiquimod—CYP3A4—Doxorubicin—breast cancer	0.00399	0.00954	CbGbCtD
Imiquimod—TLR7—uterus—breast cancer	0.00338	0.0901	CbGeAlD
Imiquimod—TLR7—female reproductive system—breast cancer	0.00304	0.081	CbGeAlD
Imiquimod—TLR7—adrenal gland—breast cancer	0.00297	0.079	CbGeAlD
Imiquimod—TLR8—lymph node—breast cancer	0.00282	0.0751	CbGeAlD
Imiquimod—TLR7—endocrine gland—breast cancer	0.00257	0.0685	CbGeAlD
Imiquimod—TLR7—lymph node—breast cancer	0.00178	0.0474	CbGeAlD
Imiquimod—CYP1A2—nipple—breast cancer	0.0011	0.0292	CbGeAlD
Imiquimod—CYP1A2—endocrine gland—breast cancer	0.000464	0.0123	CbGeAlD
Imiquimod—CYP3A4—female reproductive system—breast cancer	0.000397	0.0106	CbGeAlD
Imiquimod—CYP3A4—endocrine gland—breast cancer	0.000336	0.00893	CbGeAlD
Imiquimod—Chills—Methotrexate—breast cancer	3.66e-05	0.000158	CcSEcCtD
Imiquimod—Headache—Mitoxantrone—breast cancer	3.65e-05	0.000157	CcSEcCtD
Imiquimod—Headache—Irinotecan—breast cancer	3.65e-05	0.000157	CcSEcCtD
Imiquimod—Insomnia—Docetaxel—breast cancer	3.64e-05	0.000157	CcSEcCtD
Imiquimod—Paraesthesia—Docetaxel—breast cancer	3.61e-05	0.000156	CcSEcCtD
Imiquimod—Erythema multiforme—Epirubicin—breast cancer	3.61e-05	0.000156	CcSEcCtD
Imiquimod—Alopecia—Methotrexate—breast cancer	3.61e-05	0.000156	CcSEcCtD
Imiquimod—Vomiting—Gemcitabine—breast cancer	3.61e-05	0.000156	CcSEcCtD
Imiquimod—Dyspnoea—Docetaxel—breast cancer	3.59e-05	0.000155	CcSEcCtD
Imiquimod—Somnolence—Docetaxel—breast cancer	3.58e-05	0.000154	CcSEcCtD
Imiquimod—Mental disorder—Methotrexate—breast cancer	3.58e-05	0.000154	CcSEcCtD
Imiquimod—Rash—Gemcitabine—breast cancer	3.58e-05	0.000154	CcSEcCtD
Imiquimod—Dermatitis—Gemcitabine—breast cancer	3.57e-05	0.000154	CcSEcCtD
Imiquimod—Eye disorder—Epirubicin—breast cancer	3.57e-05	0.000154	CcSEcCtD
Imiquimod—Tinnitus—Epirubicin—breast cancer	3.56e-05	0.000154	CcSEcCtD
Imiquimod—Malnutrition—Methotrexate—breast cancer	3.56e-05	0.000153	CcSEcCtD
Imiquimod—Erythema—Methotrexate—breast cancer	3.56e-05	0.000153	CcSEcCtD
Imiquimod—Haemoglobin—Doxorubicin—breast cancer	3.55e-05	0.000153	CcSEcCtD
Imiquimod—Headache—Gemcitabine—breast cancer	3.55e-05	0.000153	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Capecitabine—breast cancer	3.55e-05	0.000153	CcSEcCtD
Imiquimod—Flushing—Epirubicin—breast cancer	3.55e-05	0.000153	CcSEcCtD
Imiquimod—Vomiting—Fluorouracil—breast cancer	3.55e-05	0.000153	CcSEcCtD
Imiquimod—Rhinitis—Doxorubicin—breast cancer	3.55e-05	0.000153	CcSEcCtD
Imiquimod—Dyspepsia—Docetaxel—breast cancer	3.54e-05	0.000153	CcSEcCtD
Imiquimod—Haemorrhage—Doxorubicin—breast cancer	3.54e-05	0.000153	CcSEcCtD
Imiquimod—Insomnia—Capecitabine—breast cancer	3.53e-05	0.000152	CcSEcCtD
Imiquimod—Rash—Fluorouracil—breast cancer	3.52e-05	0.000152	CcSEcCtD
Imiquimod—Dermatitis—Fluorouracil—breast cancer	3.51e-05	0.000152	CcSEcCtD
Imiquimod—Pharyngitis—Doxorubicin—breast cancer	3.51e-05	0.000151	CcSEcCtD
Imiquimod—Paraesthesia—Capecitabine—breast cancer	3.5e-05	0.000151	CcSEcCtD
Imiquimod—Decreased appetite—Docetaxel—breast cancer	3.5e-05	0.000151	CcSEcCtD
Imiquimod—Hypersensitivity—Paclitaxel—breast cancer	3.5e-05	0.000151	CcSEcCtD
Imiquimod—Headache—Fluorouracil—breast cancer	3.49e-05	0.000151	CcSEcCtD
Imiquimod—Urinary tract disorder—Doxorubicin—breast cancer	3.49e-05	0.000151	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Docetaxel—breast cancer	3.48e-05	0.00015	CcSEcCtD
Imiquimod—Connective tissue disorder—Doxorubicin—breast cancer	3.47e-05	0.00015	CcSEcCtD
Imiquimod—Dyspnoea—Capecitabine—breast cancer	3.47e-05	0.00015	CcSEcCtD
Imiquimod—Fatigue—Docetaxel—breast cancer	3.47e-05	0.00015	CcSEcCtD
Imiquimod—Angiopathy—Epirubicin—breast cancer	3.47e-05	0.00015	CcSEcCtD
Imiquimod—Urethral disorder—Doxorubicin—breast cancer	3.47e-05	0.00015	CcSEcCtD
Imiquimod—Nausea—Mitoxantrone—breast cancer	3.46e-05	0.000149	CcSEcCtD
Imiquimod—Nausea—Irinotecan—breast cancer	3.46e-05	0.000149	CcSEcCtD
Imiquimod—Immune system disorder—Epirubicin—breast cancer	3.45e-05	0.000149	CcSEcCtD
Imiquimod—Mediastinal disorder—Epirubicin—breast cancer	3.44e-05	0.000149	CcSEcCtD
Imiquimod—Pain—Docetaxel—breast cancer	3.44e-05	0.000149	CcSEcCtD
Imiquimod—Back pain—Methotrexate—breast cancer	3.44e-05	0.000148	CcSEcCtD
Imiquimod—Dyspepsia—Capecitabine—breast cancer	3.43e-05	0.000148	CcSEcCtD
Imiquimod—Chills—Epirubicin—breast cancer	3.43e-05	0.000148	CcSEcCtD
Imiquimod—Arrhythmia—Epirubicin—breast cancer	3.41e-05	0.000147	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—breast cancer	3.41e-05	0.000147	CcSEcCtD
Imiquimod—Asthenia—Paclitaxel—breast cancer	3.41e-05	0.000147	CcSEcCtD
Imiquimod—Decreased appetite—Capecitabine—breast cancer	3.39e-05	0.000146	CcSEcCtD
Imiquimod—Alopecia—Epirubicin—breast cancer	3.38e-05	0.000146	CcSEcCtD
Imiquimod—Nausea—Gemcitabine—breast cancer	3.37e-05	0.000145	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Capecitabine—breast cancer	3.36e-05	0.000145	CcSEcCtD
Imiquimod—Fatigue—Capecitabine—breast cancer	3.36e-05	0.000145	CcSEcCtD
Imiquimod—Pruritus—Paclitaxel—breast cancer	3.36e-05	0.000145	CcSEcCtD
Imiquimod—Mental disorder—Epirubicin—breast cancer	3.35e-05	0.000145	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—breast cancer	3.34e-05	0.000144	CcSEcCtD
Imiquimod—Pain—Capecitabine—breast cancer	3.33e-05	0.000144	CcSEcCtD
Imiquimod—Malnutrition—Epirubicin—breast cancer	3.33e-05	0.000144	CcSEcCtD
Imiquimod—Erythema—Epirubicin—breast cancer	3.33e-05	0.000144	CcSEcCtD
Imiquimod—Feeling abnormal—Docetaxel—breast cancer	3.32e-05	0.000143	CcSEcCtD
Imiquimod—Nausea—Fluorouracil—breast cancer	3.31e-05	0.000143	CcSEcCtD
Imiquimod—Eye disorder—Doxorubicin—breast cancer	3.3e-05	0.000143	CcSEcCtD
Imiquimod—Ill-defined disorder—Methotrexate—breast cancer	3.3e-05	0.000142	CcSEcCtD
Imiquimod—Tinnitus—Doxorubicin—breast cancer	3.3e-05	0.000142	CcSEcCtD
Imiquimod—Gastrointestinal pain—Docetaxel—breast cancer	3.29e-05	0.000142	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—breast cancer	3.28e-05	0.000142	CcSEcCtD
Imiquimod—Diarrhoea—Paclitaxel—breast cancer	3.25e-05	0.00014	CcSEcCtD
Imiquimod—Back pain—Epirubicin—breast cancer	3.22e-05	0.000139	CcSEcCtD
Imiquimod—Feeling abnormal—Capecitabine—breast cancer	3.21e-05	0.000139	CcSEcCtD
Imiquimod—Angiopathy—Doxorubicin—breast cancer	3.21e-05	0.000138	CcSEcCtD
Imiquimod—Malaise—Methotrexate—breast cancer	3.21e-05	0.000138	CcSEcCtD
Imiquimod—Immune system disorder—Doxorubicin—breast cancer	3.19e-05	0.000138	CcSEcCtD
Imiquimod—Gastrointestinal pain—Capecitabine—breast cancer	3.19e-05	0.000138	CcSEcCtD
Imiquimod—Mediastinal disorder—Doxorubicin—breast cancer	3.19e-05	0.000138	CcSEcCtD
Imiquimod—Abdominal pain—Docetaxel—breast cancer	3.18e-05	0.000137	CcSEcCtD
Imiquimod—Body temperature increased—Docetaxel—breast cancer	3.18e-05	0.000137	CcSEcCtD
Imiquimod—Chills—Doxorubicin—breast cancer	3.17e-05	0.000137	CcSEcCtD
Imiquimod—Arrhythmia—Doxorubicin—breast cancer	3.16e-05	0.000136	CcSEcCtD
Imiquimod—Dizziness—Paclitaxel—breast cancer	3.14e-05	0.000136	CcSEcCtD
Imiquimod—Alopecia—Doxorubicin—breast cancer	3.12e-05	0.000135	CcSEcCtD
Imiquimod—Cough—Methotrexate—breast cancer	3.1e-05	0.000134	CcSEcCtD
Imiquimod—Mental disorder—Doxorubicin—breast cancer	3.1e-05	0.000134	CcSEcCtD
Imiquimod—Urticaria—Capecitabine—breast cancer	3.1e-05	0.000134	CcSEcCtD
Imiquimod—Ill-defined disorder—Epirubicin—breast cancer	3.09e-05	0.000133	CcSEcCtD
Imiquimod—Abdominal pain—Capecitabine—breast cancer	3.08e-05	0.000133	CcSEcCtD
Imiquimod—Body temperature increased—Capecitabine—breast cancer	3.08e-05	0.000133	CcSEcCtD
Imiquimod—Convulsion—Methotrexate—breast cancer	3.08e-05	0.000133	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—breast cancer	3.08e-05	0.000133	CcSEcCtD
Imiquimod—Erythema—Doxorubicin—breast cancer	3.08e-05	0.000133	CcSEcCtD
Imiquimod—Agitation—Epirubicin—breast cancer	3.06e-05	0.000132	CcSEcCtD
Imiquimod—Chest pain—Methotrexate—breast cancer	3.03e-05	0.000131	CcSEcCtD
Imiquimod—Arthralgia—Methotrexate—breast cancer	3.03e-05	0.000131	CcSEcCtD
Imiquimod—Myalgia—Methotrexate—breast cancer	3.03e-05	0.000131	CcSEcCtD
Imiquimod—Vomiting—Paclitaxel—breast cancer	3.02e-05	0.00013	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.01e-05	0.00013	CcSEcCtD
Imiquimod—Malaise—Epirubicin—breast cancer	3e-05	0.000129	CcSEcCtD
Imiquimod—Rash—Paclitaxel—breast cancer	2.99e-05	0.000129	CcSEcCtD
Imiquimod—Dermatitis—Paclitaxel—breast cancer	2.99e-05	0.000129	CcSEcCtD
Imiquimod—Discomfort—Methotrexate—breast cancer	2.99e-05	0.000129	CcSEcCtD
Imiquimod—Syncope—Epirubicin—breast cancer	2.98e-05	0.000129	CcSEcCtD
Imiquimod—Back pain—Doxorubicin—breast cancer	2.98e-05	0.000129	CcSEcCtD
Imiquimod—Headache—Paclitaxel—breast cancer	2.98e-05	0.000128	CcSEcCtD
Imiquimod—Hypersensitivity—Docetaxel—breast cancer	2.97e-05	0.000128	CcSEcCtD
Imiquimod—Palpitations—Epirubicin—breast cancer	2.94e-05	0.000127	CcSEcCtD
Imiquimod—Loss of consciousness—Epirubicin—breast cancer	2.92e-05	0.000126	CcSEcCtD
Imiquimod—Cough—Epirubicin—breast cancer	2.9e-05	0.000125	CcSEcCtD
Imiquimod—Asthenia—Docetaxel—breast cancer	2.89e-05	0.000125	CcSEcCtD
Imiquimod—Convulsion—Epirubicin—breast cancer	2.88e-05	0.000124	CcSEcCtD
Imiquimod—Infection—Methotrexate—breast cancer	2.88e-05	0.000124	CcSEcCtD
Imiquimod—Hypertension—Epirubicin—breast cancer	2.87e-05	0.000124	CcSEcCtD
Imiquimod—Hypersensitivity—Capecitabine—breast cancer	2.87e-05	0.000124	CcSEcCtD
Imiquimod—Ill-defined disorder—Doxorubicin—breast cancer	2.86e-05	0.000123	CcSEcCtD
Imiquimod—Pruritus—Docetaxel—breast cancer	2.85e-05	0.000123	CcSEcCtD
Imiquimod—Nervous system disorder—Methotrexate—breast cancer	2.85e-05	0.000123	CcSEcCtD
Imiquimod—Arthralgia—Epirubicin—breast cancer	2.83e-05	0.000122	CcSEcCtD
Imiquimod—Chest pain—Epirubicin—breast cancer	2.83e-05	0.000122	CcSEcCtD
Imiquimod—Myalgia—Epirubicin—breast cancer	2.83e-05	0.000122	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—breast cancer	2.83e-05	0.000122	CcSEcCtD
Imiquimod—Anxiety—Epirubicin—breast cancer	2.82e-05	0.000122	CcSEcCtD
Imiquimod—Nausea—Paclitaxel—breast cancer	2.82e-05	0.000122	CcSEcCtD
Imiquimod—Skin disorder—Methotrexate—breast cancer	2.82e-05	0.000122	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.81e-05	0.000121	CcSEcCtD
Imiquimod—Hyperhidrosis—Methotrexate—breast cancer	2.8e-05	0.000121	CcSEcCtD
Imiquimod—Discomfort—Epirubicin—breast cancer	2.8e-05	0.000121	CcSEcCtD
Imiquimod—Asthenia—Capecitabine—breast cancer	2.8e-05	0.000121	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—breast cancer	2.78e-05	0.00012	CcSEcCtD
Imiquimod—Dry mouth—Epirubicin—breast cancer	2.77e-05	0.00012	CcSEcCtD
Imiquimod—Anorexia—Methotrexate—breast cancer	2.77e-05	0.000119	CcSEcCtD
Imiquimod—Syncope—Doxorubicin—breast cancer	2.76e-05	0.000119	CcSEcCtD
Imiquimod—Pruritus—Capecitabine—breast cancer	2.76e-05	0.000119	CcSEcCtD
Imiquimod—Diarrhoea—Docetaxel—breast cancer	2.75e-05	0.000119	CcSEcCtD
Imiquimod—Palpitations—Doxorubicin—breast cancer	2.72e-05	0.000117	CcSEcCtD
Imiquimod—Oedema—Epirubicin—breast cancer	2.72e-05	0.000117	CcSEcCtD
Imiquimod—Loss of consciousness—Doxorubicin—breast cancer	2.71e-05	0.000117	CcSEcCtD
Imiquimod—Infection—Epirubicin—breast cancer	2.7e-05	0.000116	CcSEcCtD
Imiquimod—Cough—Doxorubicin—breast cancer	2.69e-05	0.000116	CcSEcCtD
Imiquimod—Shock—Epirubicin—breast cancer	2.67e-05	0.000115	CcSEcCtD
Imiquimod—Convulsion—Doxorubicin—breast cancer	2.67e-05	0.000115	CcSEcCtD
Imiquimod—Diarrhoea—Capecitabine—breast cancer	2.67e-05	0.000115	CcSEcCtD
Imiquimod—Nervous system disorder—Epirubicin—breast cancer	2.66e-05	0.000115	CcSEcCtD
Imiquimod—Dizziness—Docetaxel—breast cancer	2.66e-05	0.000115	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—breast cancer	2.66e-05	0.000115	CcSEcCtD
Imiquimod—Tachycardia—Epirubicin—breast cancer	2.65e-05	0.000114	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methotrexate—breast cancer	2.64e-05	0.000114	CcSEcCtD
Imiquimod—Skin disorder—Epirubicin—breast cancer	2.64e-05	0.000114	CcSEcCtD
Imiquimod—Hyperhidrosis—Epirubicin—breast cancer	2.62e-05	0.000113	CcSEcCtD
Imiquimod—Insomnia—Methotrexate—breast cancer	2.62e-05	0.000113	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—breast cancer	2.62e-05	0.000113	CcSEcCtD
Imiquimod—Arthralgia—Doxorubicin—breast cancer	2.62e-05	0.000113	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—breast cancer	2.62e-05	0.000113	CcSEcCtD
Imiquimod—Anxiety—Doxorubicin—breast cancer	2.61e-05	0.000113	CcSEcCtD
Imiquimod—Paraesthesia—Methotrexate—breast cancer	2.61e-05	0.000112	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.6e-05	0.000112	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—breast cancer	2.59e-05	0.000112	CcSEcCtD
Imiquimod—Anorexia—Epirubicin—breast cancer	2.59e-05	0.000112	CcSEcCtD
Imiquimod—Dyspnoea—Methotrexate—breast cancer	2.59e-05	0.000112	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	2.58e-05	0.00023	CbGpPWpGaD
Imiquimod—Somnolence—Methotrexate—breast cancer	2.58e-05	0.000111	CcSEcCtD
Imiquimod—Dizziness—Capecitabine—breast cancer	2.58e-05	0.000111	CcSEcCtD
Imiquimod—TLR8—Immune System—KRAS—breast cancer	2.57e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—COMT—breast cancer	2.57e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—breast cancer	2.57e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	2.57e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—NCOA2—breast cancer	2.57e-05	0.000229	CbGpPWpGaD
Imiquimod—Dry mouth—Doxorubicin—breast cancer	2.56e-05	0.000111	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—GSTP1—breast cancer	2.56e-05	0.000228	CbGpPWpGaD
Imiquimod—Vomiting—Docetaxel—breast cancer	2.56e-05	0.00011	CcSEcCtD
Imiquimod—Dyspepsia—Methotrexate—breast cancer	2.55e-05	0.00011	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—breast cancer	2.55e-05	0.000227	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDKN1A—breast cancer	2.55e-05	0.000226	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTEN—breast cancer	2.54e-05	0.000226	CbGpPWpGaD
Imiquimod—Rash—Docetaxel—breast cancer	2.54e-05	0.00011	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—COMT—breast cancer	2.54e-05	0.000226	CbGpPWpGaD
Imiquimod—Dermatitis—Docetaxel—breast cancer	2.54e-05	0.000109	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HADHB—breast cancer	2.53e-05	0.000225	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTP1—breast cancer	2.53e-05	0.000225	CbGpPWpGaD
Imiquimod—Decreased appetite—Methotrexate—breast cancer	2.52e-05	0.000109	CcSEcCtD
Imiquimod—Headache—Docetaxel—breast cancer	2.52e-05	0.000109	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—AKT1—breast cancer	2.51e-05	0.000224	CbGpPWpGaD
Imiquimod—Oedema—Doxorubicin—breast cancer	2.51e-05	0.000108	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Methotrexate—breast cancer	2.5e-05	0.000108	CcSEcCtD
Imiquimod—Fatigue—Methotrexate—breast cancer	2.5e-05	0.000108	CcSEcCtD
Imiquimod—Infection—Doxorubicin—breast cancer	2.5e-05	0.000108	CcSEcCtD
Imiquimod—TLR7—Immune System—MAPK8—breast cancer	2.49e-05	0.000221	CbGpPWpGaD
Imiquimod—Pain—Methotrexate—breast cancer	2.48e-05	0.000107	CcSEcCtD
Imiquimod—Vomiting—Capecitabine—breast cancer	2.48e-05	0.000107	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Epirubicin—breast cancer	2.47e-05	0.000107	CcSEcCtD
Imiquimod—Shock—Doxorubicin—breast cancer	2.47e-05	0.000107	CcSEcCtD
Imiquimod—Nervous system disorder—Doxorubicin—breast cancer	2.46e-05	0.000106	CcSEcCtD
Imiquimod—Rash—Capecitabine—breast cancer	2.46e-05	0.000106	CcSEcCtD
Imiquimod—Insomnia—Epirubicin—breast cancer	2.46e-05	0.000106	CcSEcCtD
Imiquimod—Dermatitis—Capecitabine—breast cancer	2.46e-05	0.000106	CcSEcCtD
Imiquimod—Tachycardia—Doxorubicin—breast cancer	2.45e-05	0.000106	CcSEcCtD
Imiquimod—Headache—Capecitabine—breast cancer	2.44e-05	0.000105	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—breast cancer	2.44e-05	0.000105	CcSEcCtD
Imiquimod—Paraesthesia—Epirubicin—breast cancer	2.44e-05	0.000105	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—breast cancer	2.43e-05	0.000105	CcSEcCtD
Imiquimod—Dyspnoea—Epirubicin—breast cancer	2.42e-05	0.000104	CcSEcCtD
Imiquimod—Somnolence—Epirubicin—breast cancer	2.41e-05	0.000104	CcSEcCtD
Imiquimod—Anorexia—Doxorubicin—breast cancer	2.39e-05	0.000103	CcSEcCtD
Imiquimod—Nausea—Docetaxel—breast cancer	2.39e-05	0.000103	CcSEcCtD
Imiquimod—Feeling abnormal—Methotrexate—breast cancer	2.39e-05	0.000103	CcSEcCtD
Imiquimod—Dyspepsia—Epirubicin—breast cancer	2.39e-05	0.000103	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methotrexate—breast cancer	2.37e-05	0.000102	CcSEcCtD
Imiquimod—TLR8—Immune System—PIK3CA—breast cancer	2.36e-05	0.00021	CbGpPWpGaD
Imiquimod—Decreased appetite—Epirubicin—breast cancer	2.36e-05	0.000102	CcSEcCtD
Imiquimod—TLR7—Immune System—SRC—breast cancer	2.36e-05	0.00021	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTM1—breast cancer	2.35e-05	0.000209	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Epirubicin—breast cancer	2.34e-05	0.000101	CcSEcCtD
Imiquimod—Fatigue—Epirubicin—breast cancer	2.34e-05	0.000101	CcSEcCtD
Imiquimod—Pain—Epirubicin—breast cancer	2.32e-05	0.0001	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTM1—breast cancer	2.32e-05	0.000206	CbGpPWpGaD
Imiquimod—Nausea—Capecitabine—breast cancer	2.32e-05	9.99e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—breast cancer	2.31e-05	0.000206	CbGpPWpGaD
Imiquimod—Urticaria—Methotrexate—breast cancer	2.3e-05	9.95e-05	CcSEcCtD
Imiquimod—Abdominal pain—Methotrexate—breast cancer	2.29e-05	9.9e-05	CcSEcCtD
Imiquimod—Body temperature increased—Methotrexate—breast cancer	2.29e-05	9.9e-05	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.29e-05	9.88e-05	CcSEcCtD
Imiquimod—Insomnia—Doxorubicin—breast cancer	2.27e-05	9.81e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—STAT3—breast cancer	2.27e-05	0.000202	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.27e-05	0.000202	CbGpPWpGaD
Imiquimod—Paraesthesia—Doxorubicin—breast cancer	2.26e-05	9.74e-05	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.24e-05	0.000199	CbGpPWpGaD
Imiquimod—Dyspnoea—Doxorubicin—breast cancer	2.24e-05	9.67e-05	CcSEcCtD
Imiquimod—Feeling abnormal—Epirubicin—breast cancer	2.24e-05	9.66e-05	CcSEcCtD
Imiquimod—Somnolence—Doxorubicin—breast cancer	2.23e-05	9.64e-05	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—CYP1A1—breast cancer	2.23e-05	0.000198	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Epirubicin—breast cancer	2.22e-05	9.58e-05	CcSEcCtD
Imiquimod—Dyspepsia—Doxorubicin—breast cancer	2.21e-05	9.54e-05	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP1A1—breast cancer	2.2e-05	0.000196	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HRAS—breast cancer	2.19e-05	0.000195	CbGpPWpGaD
Imiquimod—Decreased appetite—Doxorubicin—breast cancer	2.18e-05	9.43e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—MAPK3—breast cancer	2.17e-05	0.000193	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—breast cancer	2.17e-05	0.000193	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Doxorubicin—breast cancer	2.17e-05	9.36e-05	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.17e-05	0.000193	CbGpPWpGaD
Imiquimod—Fatigue—Doxorubicin—breast cancer	2.17e-05	9.35e-05	CcSEcCtD
Imiquimod—Urticaria—Epirubicin—breast cancer	2.16e-05	9.31e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	2.15e-05	0.000191	CbGpPWpGaD
Imiquimod—Pain—Doxorubicin—breast cancer	2.15e-05	9.27e-05	CcSEcCtD
Imiquimod—Abdominal pain—Epirubicin—breast cancer	2.15e-05	9.26e-05	CcSEcCtD
Imiquimod—Body temperature increased—Epirubicin—breast cancer	2.15e-05	9.26e-05	CcSEcCtD
Imiquimod—Hypersensitivity—Methotrexate—breast cancer	2.14e-05	9.23e-05	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.14e-05	0.00019	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.11e-05	0.000187	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—breast cancer	2.09e-05	0.000186	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	2.08e-05	0.000185	CbGpPWpGaD
Imiquimod—Asthenia—Methotrexate—breast cancer	2.08e-05	8.98e-05	CcSEcCtD
Imiquimod—Feeling abnormal—Doxorubicin—breast cancer	2.07e-05	8.94e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—EGFR—breast cancer	2.07e-05	0.000184	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Doxorubicin—breast cancer	2.05e-05	8.87e-05	CcSEcCtD
Imiquimod—Pruritus—Methotrexate—breast cancer	2.05e-05	8.86e-05	CcSEcCtD
Imiquimod—Hypersensitivity—Epirubicin—breast cancer	2e-05	8.63e-05	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—breast cancer	2e-05	8.61e-05	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—breast cancer	1.99e-05	8.57e-05	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—breast cancer	1.99e-05	8.57e-05	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—COMT—breast cancer	1.99e-05	0.000177	CbGpPWpGaD
Imiquimod—Diarrhoea—Methotrexate—breast cancer	1.99e-05	8.57e-05	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.98e-05	0.000176	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.96e-05	0.000174	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KRAS—breast cancer	1.95e-05	0.000173	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.95e-05	0.000173	CbGpPWpGaD
Imiquimod—Asthenia—Epirubicin—breast cancer	1.95e-05	8.41e-05	CcSEcCtD
Imiquimod—TLR8—Immune System—AKT1—breast cancer	1.93e-05	0.000172	CbGpPWpGaD
Imiquimod—Pruritus—Epirubicin—breast cancer	1.92e-05	8.29e-05	CcSEcCtD
Imiquimod—Dizziness—Methotrexate—breast cancer	1.92e-05	8.28e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—breast cancer	1.92e-05	0.000171	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—breast cancer	1.89e-05	0.000168	CbGpPWpGaD
Imiquimod—Diarrhoea—Epirubicin—breast cancer	1.86e-05	8.02e-05	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—breast cancer	1.85e-05	7.99e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—breast cancer	1.85e-05	0.000165	CbGpPWpGaD
Imiquimod—Vomiting—Methotrexate—breast cancer	1.84e-05	7.96e-05	CcSEcCtD
Imiquimod—Rash—Methotrexate—breast cancer	1.83e-05	7.9e-05	CcSEcCtD
Imiquimod—Dermatitis—Methotrexate—breast cancer	1.83e-05	7.89e-05	CcSEcCtD
Imiquimod—Headache—Methotrexate—breast cancer	1.82e-05	7.84e-05	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.82e-05	0.000162	CbGpPWpGaD
Imiquimod—Asthenia—Doxorubicin—breast cancer	1.8e-05	7.78e-05	CcSEcCtD
Imiquimod—Dizziness—Epirubicin—breast cancer	1.8e-05	7.75e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—SYNJ2—breast cancer	1.79e-05	0.00016	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3CA—breast cancer	1.79e-05	0.000159	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.79e-05	0.000159	CbGpPWpGaD
Imiquimod—Pruritus—Doxorubicin—breast cancer	1.78e-05	7.67e-05	CcSEcCtD
Imiquimod—Vomiting—Epirubicin—breast cancer	1.73e-05	7.45e-05	CcSEcCtD
Imiquimod—Nausea—Methotrexate—breast cancer	1.72e-05	7.44e-05	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.72e-05	0.000153	CbGpPWpGaD
Imiquimod—Diarrhoea—Doxorubicin—breast cancer	1.72e-05	7.42e-05	CcSEcCtD
Imiquimod—Rash—Epirubicin—breast cancer	1.71e-05	7.39e-05	CcSEcCtD
Imiquimod—Dermatitis—Epirubicin—breast cancer	1.71e-05	7.38e-05	CcSEcCtD
Imiquimod—Headache—Epirubicin—breast cancer	1.7e-05	7.34e-05	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.7e-05	0.000151	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NDUFS3—breast cancer	1.67e-05	0.000148	CbGpPWpGaD
Imiquimod—Dizziness—Doxorubicin—breast cancer	1.66e-05	7.17e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—HRAS—breast cancer	1.66e-05	0.000147	CbGpPWpGaD
Imiquimod—Nausea—Epirubicin—breast cancer	1.61e-05	6.96e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	1.6e-05	0.000143	CbGpPWpGaD
Imiquimod—Vomiting—Doxorubicin—breast cancer	1.6e-05	6.89e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—IL6—breast cancer	1.59e-05	0.000141	CbGpPWpGaD
Imiquimod—Rash—Doxorubicin—breast cancer	1.58e-05	6.84e-05	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—breast cancer	1.58e-05	6.83e-05	CcSEcCtD
Imiquimod—Headache—Doxorubicin—breast cancer	1.57e-05	6.79e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—CHST9—breast cancer	1.57e-05	0.00014	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	1.53e-05	0.000136	CbGpPWpGaD
Imiquimod—Nausea—Doxorubicin—breast cancer	1.49e-05	6.44e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	1.49e-05	0.000133	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—COX11—breast cancer	1.49e-05	0.000132	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—breast cancer	1.46e-05	0.00013	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	1.46e-05	0.00013	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	1.42e-05	0.000126	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SYNJ2—breast cancer	1.39e-05	0.000123	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CDA—breast cancer	1.36e-05	0.000121	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SHMT1—breast cancer	1.36e-05	0.000121	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	1.34e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.33e-05	0.000118	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLCO1B1—breast cancer	1.31e-05	0.000116	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A5—breast cancer	1.31e-05	0.000116	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NDUFS3—breast cancer	1.29e-05	0.000115	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.28e-05	0.000114	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APRT—breast cancer	1.26e-05	0.000112	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.24e-05	0.00011	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.24e-05	0.00011	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CHST9—breast cancer	1.21e-05	0.000108	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ESRRA—breast cancer	1.19e-05	0.000106	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ANGPTL4—breast cancer	1.19e-05	0.000106	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—COX11—breast cancer	1.15e-05	0.000102	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.13e-05	0.000101	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPI—breast cancer	1.13e-05	0.0001	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HADHB—breast cancer	1.13e-05	0.0001	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.08e-05	9.59e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALDH7A1—breast cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALDH1A1—breast cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.06e-05	9.45e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SHMT1—breast cancer	1.05e-05	9.34e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CDA—breast cancer	1.05e-05	9.34e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UMPS—breast cancer	1.03e-05	9.17e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NME1—breast cancer	1.03e-05	9.17e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FHL2—breast cancer	1.03e-05	9.17e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PHGDH—breast cancer	1.03e-05	9.17e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADSL—breast cancer	1.03e-05	9.17e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HPSE—breast cancer	1.01e-05	8.99e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BRIP1—breast cancer	1.01e-05	8.99e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LDHB—breast cancer	1.01e-05	8.99e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A5—breast cancer	1.01e-05	8.99e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.01e-05	8.99e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APRT—breast cancer	9.76e-06	8.68e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTA3—breast cancer	9.58e-06	8.52e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMMR—breast cancer	9.58e-06	8.52e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCC1—breast cancer	9.58e-06	8.52e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARGC1B—breast cancer	9.28e-06	8.25e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ESRRA—breast cancer	9.18e-06	8.16e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.18e-06	8.16e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	9.04e-06	8.04e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	9.04e-06	8.04e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA9—breast cancer	8.77e-06	7.8e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTA4—breast cancer	8.77e-06	7.8e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPI—breast cancer	8.7e-06	7.74e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HADHB—breast cancer	8.7e-06	7.74e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	8.65e-06	7.7e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	8.57e-06	7.62e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX2—breast cancer	8.54e-06	7.6e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTA2—breast cancer	8.54e-06	7.6e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SULT1A1—breast cancer	8.44e-06	7.5e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX4—breast cancer	8.44e-06	7.5e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.3e-06	7.38e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.3e-06	7.38e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—IDH1—breast cancer	8.24e-06	7.33e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTA1—breast cancer	8.24e-06	7.33e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAT2—breast cancer	8.15e-06	7.25e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PHGDH—breast cancer	7.96e-06	7.08e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NME1—breast cancer	7.96e-06	7.08e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FHL2—breast cancer	7.96e-06	7.08e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UMPS—breast cancer	7.96e-06	7.08e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADSL—breast cancer	7.96e-06	7.08e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LDHB—breast cancer	7.8e-06	6.94e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HPSE—breast cancer	7.8e-06	6.94e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BRIP1—breast cancer	7.8e-06	6.94e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTA3—breast cancer	7.4e-06	6.58e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMMR—breast cancer	7.4e-06	6.58e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCC1—breast cancer	7.4e-06	6.58e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.37e-06	6.55e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.16e-06	6.37e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—DPYD—breast cancer	7.15e-06	6.35e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MED12—breast cancer	7.15e-06	6.35e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALDOA—breast cancer	7.03e-06	6.26e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOA3—breast cancer	6.83e-06	6.07e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A2—breast cancer	6.78e-06	6.03e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTA4—breast cancer	6.76e-06	6.02e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA9—breast cancer	6.76e-06	6.02e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	6.71e-06	5.97e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCG2—breast cancer	6.64e-06	5.91e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CPT1A—breast cancer	6.64e-06	5.91e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTR—breast cancer	6.64e-06	5.91e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTA2—breast cancer	6.59e-06	5.86e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX2—breast cancer	6.59e-06	5.86e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HPGDS—breast cancer	6.51e-06	5.79e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SULT1A1—breast cancer	6.51e-06	5.79e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX4—breast cancer	6.51e-06	5.79e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HBA1—breast cancer	6.47e-06	5.76e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—IDH1—breast cancer	6.36e-06	5.66e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTA1—breast cancer	6.36e-06	5.66e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTT1—breast cancer	6.32e-06	5.62e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ACHE—breast cancer	6.32e-06	5.62e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAT2—breast cancer	6.29e-06	5.59e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP17A1—breast cancer	5.98e-06	5.32e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ENO1—breast cancer	5.92e-06	5.27e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS1—breast cancer	5.92e-06	5.27e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.9e-06	5.25e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.82e-06	5.18e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2D6—breast cancer	5.81e-06	5.16e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOA2—breast cancer	5.7e-06	5.07e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FASN—breast cancer	5.53e-06	4.92e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MED12—breast cancer	5.51e-06	4.9e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—DPYD—breast cancer	5.51e-06	4.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BCHE—breast cancer	5.5e-06	4.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC5A5—breast cancer	5.44e-06	4.84e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALDOA—breast cancer	5.43e-06	4.83e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOA3—breast cancer	5.27e-06	4.69e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A1—breast cancer	5.25e-06	4.67e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NQO1—breast cancer	5.25e-06	4.67e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A2—breast cancer	5.23e-06	4.65e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.14e-06	4.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCG2—breast cancer	5.13e-06	4.56e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CPT1A—breast cancer	5.13e-06	4.56e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTR—breast cancer	5.13e-06	4.56e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP3A4—breast cancer	5.12e-06	4.55e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.09e-06	4.53e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP1B1—breast cancer	5.03e-06	4.48e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HPGDS—breast cancer	5.03e-06	4.47e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HBA1—breast cancer	5e-06	4.44e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSP90AA1—breast cancer	4.94e-06	4.39e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ACHE—breast cancer	4.88e-06	4.34e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTT1—breast cancer	4.88e-06	4.34e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOA1—breast cancer	4.8e-06	4.27e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—STK11—breast cancer	4.73e-06	4.21e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP19A1—breast cancer	4.73e-06	4.21e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP17A1—breast cancer	4.62e-06	4.11e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ENO1—breast cancer	4.57e-06	4.06e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS1—breast cancer	4.57e-06	4.06e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2D6—breast cancer	4.48e-06	3.99e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.44e-06	3.95e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—COMT—breast cancer	4.4e-06	3.91e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOA2—breast cancer	4.4e-06	3.91e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTP1—breast cancer	4.38e-06	3.89e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMOX1—breast cancer	4.32e-06	3.84e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ITPR1—breast cancer	4.31e-06	3.83e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FASN—breast cancer	4.27e-06	3.79e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BCHE—breast cancer	4.25e-06	3.78e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC5A5—breast cancer	4.2e-06	3.73e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCB1—breast cancer	4.15e-06	3.69e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TYMS—breast cancer	4.07e-06	3.62e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A1—breast cancer	4.05e-06	3.6e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NQO1—breast cancer	4.05e-06	3.6e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—breast cancer	4.02e-06	3.58e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOR1—breast cancer	4.02e-06	3.58e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLA2G4A—breast cancer	4.02e-06	3.58e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1B1—breast cancer	3.89e-06	3.46e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX1—breast cancer	3.85e-06	3.43e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP1A1—breast cancer	3.82e-06	3.39e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.81e-06	3.39e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ERCC2—breast cancer	3.78e-06	3.37e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOA1—breast cancer	3.71e-06	3.3e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—STK11—breast cancer	3.65e-06	3.25e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP19A1—breast cancer	3.65e-06	3.25e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—breast cancer	3.56e-06	3.16e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—COMT—breast cancer	3.4e-06	3.02e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTP1—breast cancer	3.38e-06	3.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMOX1—breast cancer	3.33e-06	2.96e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ITPR1—breast cancer	3.33e-06	2.96e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CAV1—breast cancer	3.28e-06	2.92e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCB1—breast cancer	3.2e-06	2.85e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TYMS—breast cancer	3.14e-06	2.79e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.13e-06	2.79e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—breast cancer	3.11e-06	2.76e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.11e-06	2.76e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOR1—breast cancer	3.11e-06	2.76e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CG—breast cancer	2.99e-06	2.66e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX1—breast cancer	2.97e-06	2.65e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1A1—breast cancer	2.94e-06	2.62e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ERCC2—breast cancer	2.92e-06	2.6e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—breast cancer	2.75e-06	2.44e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CD—breast cancer	2.63e-06	2.34e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—breast cancer	2.59e-06	2.31e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CAV1—breast cancer	2.53e-06	2.25e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—breast cancer	2.48e-06	2.21e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CG—breast cancer	2.31e-06	2.05e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CB—breast cancer	2.29e-06	2.04e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—breast cancer	2.27e-06	2.02e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CD—breast cancer	2.03e-06	1.8e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—breast cancer	2e-06	1.78e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTEN—breast cancer	1.98e-06	1.76e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—breast cancer	1.91e-06	1.7e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CB—breast cancer	1.77e-06	1.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—breast cancer	1.75e-06	1.56e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTEN—breast cancer	1.53e-06	1.36e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CA—breast cancer	1.4e-06	1.24e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—breast cancer	1.14e-06	1.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CA—breast cancer	1.08e-06	9.58e-06	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—breast cancer	8.8e-07	7.83e-06	CbGpPWpGaD
